Observational Study of the Use of octaplasLG®.

NCT03369314 · clinicaltrials.gov ↗

COMPLETED

Status

263

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombotic Thrombocytopenic Purpura

Interventions

DRUG: octaplasLG®

Sponsor

Octapharma